Identification using phage display of peptides promoting targeting and internalization into HPV-transformed cell lines

Journal of Molecular Recognition

Volumn 18, Issue 2, 2005, Pages 175-182

  Robinson, Philip ^a   Stuber, Denise ^a   Deryckère, François ^a   Tedbury, Philip ^a   Lagrange, Magali ^a   Orfanoudakis, Georges ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Cell internalization; Cervical cancer; HPV; Phage display; Targeting

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; LIGAND; PEPTIDE FRAGMENT; PEPTIDE LIBRARY;

ARTICLE; BACTERIOPHAGE; CELL CULTURE; CELL LINE; CLASSIFICATION; ENDOCYTOSIS; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; NEOPLASM; PAPILLOMA VIRUS; PHYSIOLOGY; VIROLOGY; VIRUS INFECTION;

BACTERIOPHAGES; CELL LINE, TRANSFORMED; ENDOCYTOSIS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HUMANS; LIGANDS; NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; TRANSFECTION; TUMOR CELLS, CULTURED;

HUMAN PAPILLOMA VIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 14744295872     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmr.723     Document Type: Article

References (35)

1. Aina OH, Sroka TC, Chen ML, Lam KS. 2002. Therapeutic cancer targeting peptides. Biopolymers 66: 184-199.
2. Alvarez-Salas LM, Benitez-Hess ML, DiPaolo JA. 2003. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses. Antivir. Ther. 8: 265-278.
3. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective: International Biological Study on Cervical Cancer (IBSCC) Study Group. J. Natl Cancer Inst. 87: 796-802.
4. Butz K, Denk C, Ullmann A, Scheffner M, Hoppe-Seyler F. 2000. Induction of apoptosis in human papillomavirus-positive cancer cells by peptide aptamers targeting the viral E6 oncoprotein. Proc. Natl Acad. Sci. USA 97: 6693-6697.
5. Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, Hoppe-Seyler F. 2003. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 22: 5938-5945.
6. Chan SY, Delius H, Halpern AL, Bernard HU. 1995. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J. Virol. 69: 3074-3083.
7. Cheng Q, Lau WM, Tay SK, Chew SH, Ho TH, Hui KM. 2002. Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma. Int. J. Cancer 98: 419-426.
8. Ellerby HM, Arap W, Ellerby LM, Kain R, Andrusiak R, Rio GD, Krajewski S, Lombardo CR, Rao R, Ruoslahti E, Bredesen DE, Pasqualini R. 1999. Anti-cancer activity of targeted proapoptotic peptides. Nat. Med. 5: 1032-1038.
9. Felici F, Castagnoli L, Musacchio A, Jappelli R, Cesareni G. 1991. Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. J. Mol. Biol. 222: 301-310.
10. Garland SM. 2003. Can we really beat cervical cancer? Med. J. Aust. 178: 647-649.
11. Giovane C, Travė G, Briones A, Lutz Y, Wasylyk B, Weiss E. 1999. Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric scFvs blocks the E6-mediated degradation of cellular p53. J. Mol. Recognit. 12: 141-152.
12. Grifman M, Trepel M, Speece P, Gilbert LB, Arap W, Pasqualini R, Weitzman MD. 2001. Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids. Mol. Ther. 3: 964-975.
13. Horner SM, DeFilippis RA, Manuelidis L, DiMaio D. 2004. Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in HeLa cervical carcinoma cells. J. Virol. 78: 4063-4073.
14. Ivanenkov VV, Felici F, Menon AG. 1999a. Targeted delivery of multivalent phage display vectors into mammalian cells. Biochim. Biophys. Acta 1448: 463-472.
15. Ivanenkov VV, Felici F, Menon AG. 1999b. Uptake and intracellular fate of phage display vectors in mammalian cells. Biochim. Biophys. Acta 1448: 450-462.
16. Jaafari MR, Foldvari M. 2002. Targeting of liposomes to melanoma cells with high levels of ICAM-1 expression through adhesive peptides from immunoglobulin domains. J. Pharm. Sci. 91: 396-404.
17. Kelly KA, Jones DA. 2003. Isolation of a colon tumor specific binding peptide using phage display selection. Neoplasia 5: 437-444.
18. Kempf E, Weiss E, Klein P, Glacet A, Spratt S, Bourel D, Orfanoudakis G. 2001. The rescue by phage display of human recombinant Fabs to gp120 HIV-1 glycoprotein using EBV transformed lymphocytes. Mol. Biotechnol. 17: 97-108.
19. Klausner RD, Ashwell G, van Renswoude J, Harford JB, Bridges KR. 1983. Binding of apotransferrin to K562 cells: explanation of the transferrin cycle. Proc. Natl Acad. Sci. USA 80: 2263-2266.
20. Landon LA, Deutscher SL 2003. Combinatorial discovery of tumor targeting peptides using phage display. J. Cell. Biochem. 90: 509-517.
21. Lee JH, Engler JA, Collawn JF, Moore BA. 2001. Receptor mediated uptake of peptides that bind the human transferrin receptor. Eur. J. Biochem. 268: 2004-2012.
22. Mazzucchelli L, Burritt JB, Jesaitis AJ, Nusrat A, Liang TW, Gewirtz AT, Schnell FJ, Parkos CA. 1999. Cell-specific peptide binding by human neutrophils. Blood 93: 1738-1748.
23. Nees M, van Wijngaarden E, Bakos E, Schneider A, Durst M. 1998. Identification of novel molecular markers which correlate with HPV-induced tumor progression. Oncogene 16: 2447-2458.
24. Nicklin SA, Baker AH. 2002. Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy. Curr. Gene Ther. 2: 273-293.
25. Oyama T, Sykes KF, Samli KN, Minna JD, Johnston SA, Brown KC. 2003. Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents. Cancer Lett. 202: 219-230.
26. Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, Nielsen UB, Marks JD, Papahadjopoulos D, Benz CC. 2001. Tumor targeting using anti-her2 immunoliposomes. J. Control Release 74: 95-113.
27. Poul MA, Becerril B, Nielsen UB, Morisson P, Marks JD. 2000. Selection of tumor-specific internalizing human antibodies from phage libraries. J. Mol. Biol. 301: 1149-1161.
28. Rey O, Baluda MA, Park NH. 1999. Differential gene expression in neoplastic and human papillomavirus-immortalized oral keratinocytes. Oncogene 18: 827-831.
29. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S. 1999. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. New Engl. J. Med. 340: 1144-1153.
30. Venuti A, Salani D, Cirilli A, Simeone P, Muller A, Flamini S, Padley R, Bagnato A. 2002. Endothelin receptor blockade inhibits the growth of human papillomavirus-associated cervical carcinoma. Clin. Sci. (Lond.) 103: 310S-313S.
31. Wang-Johanning F, Gillespie GY, Grim J, Rancourt C, Alvarez RD, Siegal GP, Curiel DT. 1998. Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects. Cancer Res. 58: 1893-1900.
32. Wattiaux R, Laurent N, Wattiaux-De Coninck S, Jadot M. 2000. Endosomes, lysosomes: their implication in gene transfer. Adv. Drug Deliv. Rev. 41: 201-208.
33. Wolf JK, Franco EL, Arbeit JM, Shroyer KR, Wu TC, Runowicz CD, Tortolero-Luna G, Herrero R, Crum CP, Ramirez PT, Levenback C, Tanyi JL, Hasegawa Y, Lapushin R, Morris AJ, Berchuck A, Lu K, Smith DI, Kalli K, Hartmann LC, McCune K, Fishman D, Broaddus R, Cheng KW, Atkinson EN, Yamal JM, Bast RC, Felix EA, Newman RA, Mills GB, Gordinier ME, Malpica A, Burke TW, Bodurka DC, Jhingran A, Ramondetta LM, Schmandt R, Bevers MW, Levenback CF, Gordinier M, Gershenson DM, Sciscione AC, Shvartsman HS, Lu KH, Lee J, Lillie J, Deavers MT, Clifford S, Bast RC, Jr., Huh JJ, Fightmaster DL, Lotan R, Follen M, Fang X, Auersperg N, Sigal YJ, Gano J, Wharton JT, Kavanagh JJ, Jenkins AD, Tedjarati S, Baker CH, Apte S, Huang S, Killion JJ, Fidler IJ. 2003. Innovations in understanding the biology of cervical cancer. Cancer 98: 2064-2069.
34. Zhang J, Spring H, Schwab M. 2001. Neuroblastoma tumor cell-binding peptides identified through random peptide phage display. Cancer Lett. 171: 153-164.
35. zur Hausen H. 1996. Papillomavirus infections: a major cause of human cancers. Biochim. Biophys. Acta 1288: F55-F78.